Tom C. Thomas - 15 Feb 2023 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role: Officer
Signature: /s/ Tom C. Thomas
Issuer symbol: VINC
Transactions as of: 15 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Feb 2023, 15:05:35 UTC
Previous filing: 14 Dec 2022
Next filing: 10 Aug 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VINC	Stock Option (right to buy)	Award	$0	+86,000		$0.000000	86,000	15 Feb 2023	Common Stock	86,000	$1.17	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option vests in twenty-four equal monthly installments starting from February 15, 2023.

Remarks:

General Counsel and Chief Legal Officer Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.